Clinical Trials for T-cell Malignancies

Find clinical trials for t-cell malignancies. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

NCT ID: NCT07070323

This clinical trial is testing a new kind of treatment called CD5 CAR T-cell therapy for people with certain hard-to-treat blood cancers that affect T-cells, a type of immune cell. These cancers ha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Beijing, Beijing, China +2 more

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

NCT ID: NCT06316427

This clinical trial is investigating a new treatment for patients with a type of leukemia called T-cell acute lymphoblastic leukemia (T-ALL) or lymphoma that has not responded to standard therapies...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Beijing, Beijing, China +2 more

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects with Relapsed or Refractory T-cell Malignancies

NCT ID: NCT06316856

This clinical trial is studying a new type of treatment called CD5 Chimeric Antigen Receptor (CAR) T cell therapy for patients with a type of cancer known as relapsed or refractory T-cell acute lym...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Beijing, Beijing, China +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions